#National Cancer Institute

In the United States, HPV still causes nearly 34,000 cases of cancer each year.

The new trials compare the two approaches to treating women with early-stage breast cancer with long-term follow-up.

“It’s important to question intuitions and observational epidemiology studies, and fund large-scale trials,” said NCI’s Barry Kramer,...

Clinical trials are testing gel forms of oral drugs to help prevent the disease in women at an increased risk.

Researchers were able to preserve trial participants’ mental functions by avoiding the hippocampus during radiation treatment.

The drug, a PARP inhibitor, blocks proteins that help repair damaged DNA, and so can cause tumor cells that carry a BRCA mutation to die.

It is the science being supported by the Moonshot that will accelerate progress across the entire cancer continuum.

The trial will soon have nearly 40 study arms testing different targeted therapies.

Researchers studied older women with breast cancer to discover why some people are particularly susceptible to “chemo brain.”

A new study links poor access to affordable, healthy food to an increased risk of cancer death.

This minimally invasive approach may reduce the burden on children with diffuse midline glioma.

We’re interested in assessing how diet affects health—but in the context of the what, where, when, why, and how we eat.

This is, without a doubt, a time of great hope in cancer research.

In non-small cell lung cancer, new drugs like brigatinib and crizotinib can dramatically shrink tumors with an ALK alteration.

The dual-stain test addresses a critical question: How often should HPV-positive women undergo repeat screenings for cervical cancer?

The program proved as accurate as experienced pathologists at diagnosing adenocarcinomas and squamous cell carcinomas.